Seeing Is Believing
Currently out of the existing stock ratings of Dennis Ding, 9 are a BUY (75%), 3 are a HOLD (25%).
Analyst Dennis Ding works at JEFFERIES with a stock forecast success ratio of 33.33% fulfilled within 39.17 days on average.
Dennis Ding’s has documented 24 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ROIV, Roivant Sciences Ltd at 27-Sep-2023.
Analyst best performing recommendations are on NGM (NGM BIOPHARMACEUTICALS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$1.25 (45.45%)
4
21 days ago
0/5 (0%)
$1 (33.33%)
Buy
4
$1.25 (45.45%)
6
1 months 24 days ago
1/8 (12.5%)
$1.21 (43.37%)
139
Buy
5
$2.25 (81.82%)
6
1 months 24 days ago
0/13 (0%)
$2.21 (79.21%)
Buy
5
$2.08 (71.23%)
2 years 2 months 24 days ago
0/1 (0%)
$2.11 (73.01%)
Buy
7
2 years 9 months 28 days ago
0/4 (0%)
$3.7 (112.12%)
What Year was the first public recommendation made by Dennis Ding?